TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 167.00
-9.00 (-5.11%)
At close: Apr 24, 2026
TCM Biotech International Revenue
In the year 2025, TCM Biotech International had annual revenue of 685.49M TWD with 2.84% growth. TCM Biotech International had revenue of 174.99M in the quarter ending December 31, 2025, with 1.80% growth.
Revenue
685.49M
Revenue Growth
+2.84%
P/S Ratio
14.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 685.49M | 18.96M | 2.84% |
| Dec 31, 2024 | 666.53M | -303.09M | -31.26% |
| Dec 31, 2023 | 969.62M | 167.20M | 20.84% |
| Dec 31, 2022 | 802.42M | 100.38M | 14.30% |
| Dec 31, 2021 | 702.05M | -35.03M | -4.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EDOM Technology | 115.57B |
| Taiwan Printed Circuit Board Techvest | 18.37B |
| Crowell Development | 12.28B |
| Yuen Foong Yu Consumer Products | 10.65B |
| Phihong Technology | 9.80B |
| Gigastorage | 6.37B |
| Ve Wong | 5.65B |
| KMC (Kuei Meng) International | 4.68B |